Gwo-tzer Ho, PhD, co-author of a recent review of recent developments for precision medicine in IBD talks with AJG co-editor Dr. Brian Lacy about the definition and scope of precision medicine, newly discovered IBD biomarkers that could be used to guide precision therapies, and the practical and ethical implications of these new developments. (21:38)

Dr. Chey, co-author of new research comparing the effectiveness of the low FODMAP diet versus a modified NICE diet for IBS-D, speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about improvements in bloating and abdominal pain found with the low FODMAP diet, the value of individual symptom response compared to an overall “adequate relief” end point, and practical advice for guiding patients through the low FODMAP diet process. (24:05)

Dr. Gupta, co-author of recent study examining the impact of small financial incentives for completion of FIT testing, speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about why use of financial incentives to encourage health behavior is not always effective, and the behavioral economics underlying this research. This article was published in the recent Negative Issue of AJG. (15:43)

C. Mel Wilcox, MD, MSPH, co-author of new research on the causes, response to therapy, and long-term outcome of idiopathic pancreatitis, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the evolving definition of idiopathic pancreatitis, the role of EUS vs MRCP in its diagnosis, and when you should consider pancreas divisum or autoimmune disorders in your etiology. (12:35)

Austin Chiang, MD, co-author of a recent Red Section article on GI ontology in social media, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the benefits and logistics of using social media, specifically Twitter, in a GI practice, how new users can best take the first steps. (11:22)

William Lee, MD, co-author of an new article comparing complementary and alternative medicine (CAM)-induced liver injury to that caused by prescription medications, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the definition of CAM, the regulatory approval process (or lack thereof) for CAM compared to prescription medication, and the most frequent CAM and prescription offenders for drug-induced liver injury. Dr. Lee also provides advice for clinicians trying to diagnose and counsel patients with suspected CAM-induced liver injury. (15:50)

Mark S. Riddle, MD, DrPH, co-author of the new ACG Clinical Guideline, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the public health threat of acute diarrheal infections, the most effective diagnostic tests, and the appropriateness of antibiotics. The role of oral rehydration, probiotics, and anti-diarrheal medication is also discussed. (19:51)

Lisa Strate, MD, MPH, FACG, co-author of the new ACG Clinical Guideline, speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about the timing of endoscopy for management of lower GI bleeding, how to assess high-risk patients for whom colonoscopy should not be performed, and the important questions surrounding the topic that remain unanswered in the current literature. (18:22)

Steve McClave, MD, co-author of the new ACG Clinical Guideline, speaks with AJG co-Editor in Chief Dr. Brian Lacy about how to recognize nutritionally deficient patients, the most common deficiencies by condition, how to determine if a patient will tolerate enteral feeds, and the pros and cons of orgastric, nasogastric, and jejunal feeding. Dr. McClave dispels some common myths, provides advice on peripheral PN (Don’t do it!), and emphasizes the invaluable support GIs can provide for the nutritional team. (16:25)

William D. Chey, MD, FACG, presenter of the 2015 David Sun Lecture and author of a recently published review of the same topic, speaks with AJG co-Editor-in-Chief Dr. Brennan Spiegel about the evolution of food from sustenance and medicine to entertainment and enjoyment and the gradual shift back toward food as medicine and therapy for disease. Learn more about the complex interplay between food and GI symptoms and the FODMAP diet as a promising treatment approach. The emerging academic focus on diet and nutrition in GI care and the essential role of dietitians in the lives of IBS patients are also discussed. (25:35)